Additionally, ESR1, which encodes ER, ranked second in terms of MSS value in uterine leiomyosarcoma samples following PGR. ESR1 is associated with gynecologic cancers, including breast cancer, endometrial cancer, and ovarian cancer [15–17]. Here, ESR1 is linked to breast cancer.